Form 6-K Telix Pharmaceuticals For: Apr 14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2026
Commission File Number: 001-42128
Telix Pharmaceuticals Limited
(Translation of registrant’s name into English)
55 Flemington Road
North Melbourne, Victoria 3051, Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
On April 14, 2026 (Melbourne, Australia), Telix Pharmaceuticals Limited (the “Company”) filed an announcement with the Australian Securities Exchange titled “Telix Successfully
Prices and Upsizes US$600 Million Convertible Bonds” a copy of which is attached to this Form 6-K as Exhibit 99.1 and is incorporated herein by reference.
|
Press release – April 14, 2026
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Telix Pharmaceuticals Limited
|
||
|
Date: April 14, 2026
|
By:
|
/s/ Christian Krautkramer
|
|
Name: Christian Krautkramer
|
||
|
Title: Group General Counsel
|
||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
- Infosys Announces Expanded Collaboration with GlobalFoundries to Accelerate AI-Driven Transformation of IT Operations
- What CDP and SBTi's New Capital Structures Mean for Your Disclosure Strategy
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share